In an intensive Winter Session course at Brown, undergraduates learned lab techniques and performed experiments as they sought breakthrough discoveries to inform future antibiotic treatments.

Azithromycin is a versatile antibiotic used to treat a wide variety of bacterial infections, including those affecting the lungs, skin, and gastrointestinal system, as well as a number of sexually ...

Imagine that the next time you catch a stomach bug and antibiotics fail to work, you knock back a vial of clear liquid. The solution teems with bacteriophages, viruses resembling tiny rocket ships.

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...

Sulfa drugs are synthetic (man-made) medications made from sulfanilamide that contain antibacterial properties. Sulfa drugs were the first class of antibiotics ever discovered. However, many other ...

In 2023, combined revenue for Zevtera and another drug, Cresemba, reached 150 million Swiss francs, or about $166 million. With antibiotic resistance on the rise, new drugs are needed to treat a range ...

Antibiotic use in any setting—including animal agriculture—contributes to the emergence of drug-resistant bacteria, a dangerous and growing global health threat. 1 Of particular concern is the overuse ...

Antibiotics are a major tool in treating illnesses caused by bacteria, but like any tool, they should be used appropriately. If they are not, the tool may not work when we really need it. The Centers ...

This study evaluates relationship between delayed antibiotic treatment for antecedent AOM and severity of subsequent acute mastoiditis admission. Methods: A prospective observational study of ...

Replacement with non-PCV7 pneumococcal serotypes and increased pneumococcal antibiotic resistance may be responsible for the increase in incidence to pre-PCV7 rates. Surveillance of mastoiditis ...